Pro-Hamas Supporters at LSU Didn't Know What to Do When the Fraternities Showed...
Who Thought It Was a Good Idea to Bring Out 'The Lost Jedi'?
The Left’s New School Choice Playbook in Arkansas Serves as a National Warning
Supporters of President Trump Should Not Support Biden’s DOJ or its Dark Antitrust...
The Truth About the CIA
The Left’s Radicalization Of Our Children
Holly Rehder: The Only MAGA Candidate in the Race for Missouri Lt. Governor
RFK, Jr.'s Proposed 'No Spoiler Pledge' Is a Stroke of Genius
It's Time to Use American Energy As a Weapon
Why Intellectuals Don't Like Capitalism
NYPD Reveals Details About the 'Professional' Pro-Hamas Agitators Popping Up on Campuses
Liberal Reporter Triggered by Frat Boys Counterprotesting Hamas Agitators, Calls Them 'Rac...
Columbia President Breaks Overdue Silence Amid Pro-Hamas Protests
Illegal Immigrants Ambush Michigan State Capitol to Demand Driver Licenses
Trump Narrows His VP List Down to These Four Potential Candidates
Tipsheet

Rand Paul Corners Fauci on Quietly Changing Gain-of-Function Definition

AP Photo/J. Scott Applewhite, Pool

Dr. Anthony Fauci is back on Capitol Hill Thursday for questioning in front of the Senate Health Committee. 

Under questioning from Dr. Rand Paul, Fauci again attempted to redefine the meaning of gain-of-function research. 

Advertisement

Fauci has repeatedly denied his agency funded dangerous gain-of-function research at the Wuhan Institute of Virology. Recently, the National Institute of Health disputed that claim

"The fifth and final progress report for Grant R01AI110964, awarded to EcoHealth Alliance, Inc. is attached with redactions only for personally identifiable information," NIH Principal Deputy Director Larence Tabak explained in a letter to Republican Congressman James Comer. "It includes data from a research project conducted during the 2018-2019 grant period using bat coronavirus genome sequences already existing in nature."

Advertisement

"The limited experiment described the final progress report provided by EcoHealth Alliance was testing if spike proteins from naturally occurring bat coronaviruses circulating in China were capable of biding to the human ACE2 receptor in a mouse model," the letter continues. "In this limited experiment, laboratory mice infected with the SHC014 W1V1 bat coronavirus became sicker than those infected with the W1V1 bat coronavirus."

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement